Sugi Predict

Sugi Predict / Compounds / SCHEMBL19106441

SCHEMBL19106441

SCHEMBL19106441

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4ccc5c(ccc6ccccc65)c4)cc(-c4nc(-c5ccccc5)c5c(n4)sc4ccccc45)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ ATM Q13315 1/20 0.37
▸ HPGD P15428 4/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ ADORA2A P29274 2/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ RECQL P46063 1/20 0.33
▸ ELANE P08246 1/20 0.32
▸ CYP1A2 P05177 2/20 0.31
▸ ERBB2 P04626 1/20 0.31
▸ FYN P06241 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ AHR P35869 1/20 0.31
▸ F9 P00740 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106461 0.97 F9 (0.34) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106467 0.96 CYP1A2 (0.34) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106448 0.95 HPGD (0.36) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106394 0.94 MEN1 (0.36) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106459 0.94 CYP1A1 (0.34) MEN1KMT2AATMHPGDADORA2A
SCHEMBL19106423 0.93 CYP1A2 (0.35) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106414 0.92 CYP1A2 (0.35) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106437 0.92 ADORA2A (0.36) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106440 0.90 MEN1 (0.39) MEN1KMT2AATMHPGDSMN1; SMN2
SCHEMBL19106439 0.88 ADORA2A (0.40) MEN1KMT2AATMHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ATM 2511/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ATM 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback